Putnam Investments LLC Biogen Inc. Transaction History

Putnam Investments LLC

$73 Billion
Q4 2023

A detailed history of Putnam Investments LLC transactions in Biogen Inc. stock. As of the latest transaction made, Putnam Investments LLC holds 97,475 shares of BIIB stock, worth $19.4 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

97,475

Previous 96,998 0.49%

Holding current value

$19.4 Million

Previous $24.9 Million 1.18%

% of portfolio

0.03%

Previous 0.04%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$222.59 - $267.94 $106,175 - $127,807	477 Added 0.49%	97,475 $25.2 Million
Q3 2023 Nov 14, 2023	SELL	$253.3 - $285.89 $80,549 - $90,913	-318 Reduced 0.33%	96,998 $24.9 Million
Q2 2023 Aug 14, 2023	BUY	$275.25 - $318.06 $3.06 Million - $3.53 Million	11,105 Added 12.88%	97,316 $27.7 Million
Q1 2023 May 22, 2023	SELL	$256.56 - $292.34 $15.6 Million - $17.8 Million	-60,843 Reduced 41.37%	86,211 $24 Million
Q4 2022 Feb 14, 2023	BUY	$252.44 - $306.72 $25 Million - $30.3 Million	98,843 Added 205.02%	147,054 $40.7 Million
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $9.39 Million - $12.9 Million	48,211 New	48,211 $12.9 Million
Q1 2022 May 16, 2022	SELL	$193.77 - $244.14 $25.8 Million - $32.6 Million	-133,350 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $4.1 Million - $5.27 Million	-18,311 Reduced 12.07%	133,350 $32 Million
Q3 2021 Nov 15, 2021	SELL	$282.99 - $369.05 $305,912 - $398,943	-1,081 Reduced 0.71%	151,661 $42.9 Million
Q2 2021 Aug 16, 2021	SELL	$259.0 - $414.71 $19.3 Million - $30.9 Million	-74,536 Reduced 32.8%	152,742 $52.9 Million
Q1 2021 May 17, 2021	BUY	$242.95 - $284.63 $25 Million - $29.3 Million	102,793 Added 82.57%	227,278 $63.6 Million
Q4 2020 Feb 16, 2021	SELL	$236.26 - $355.63 $18.2 Million - $27.4 Million	-77,184 Reduced 38.27%	124,485 $30.5 Million
Q3 2020 Nov 16, 2020	BUY	$264.77 - $305.71 $7.02 Million - $8.1 Million	26,504 Added 15.13%	201,669 $57.2 Million
Q2 2020 Aug 14, 2020	SELL	$258.66 - $342.55 $34.1 Million - $45.1 Million	-131,642 Reduced 42.91%	175,165 $46.9 Million
Q1 2020 May 15, 2020	BUY	$268.85 - $341.04 $18.5 Million - $23.4 Million	68,737 Added 28.87%	306,807 $97.1 Million
Q4 2019 Feb 14, 2020	SELL	$220.06 - $304.07 $855,373 - $1.18 Million	-3,887 Reduced 1.61%	238,070 $70.6 Million
Q3 2019 Nov 14, 2019	BUY	$217.44 - $243.88 $6.57 Million - $7.37 Million	30,209 Added 14.27%	241,957 $56.3 Million
Q2 2019 Aug 14, 2019	BUY	$219.29 - $241.72 $364,240 - $401,496	1,661 Added 0.79%	211,748 $49.5 Million
Q1 2019 May 15, 2019	SELL	$216.71 - $338.96 $85.7 Million - $134 Million	-395,306 Reduced 65.3%	210,087 $49.7 Million
Q4 2018 Feb 14, 2019	BUY	$278.5 - $352.75 $30.3 Million - $38.4 Million	108,895 Added 21.93%	605,393 $182 Million
Q3 2018 Nov 14, 2018	BUY	$293.51 - $383.83 $107 Million - $140 Million	365,621 Added 279.36%	496,498 $175 Million
Q2 2018 Aug 14, 2018	SELL	$257.52 - $306.91 $49.1 Million - $58.5 Million	-190,583 Reduced 59.29%	130,877 $38 Million
Q1 2018 May 15, 2018	SELL	$260.13 - $367.91 $124 Million - $176 Million	-477,912 Reduced 59.79%	321,460 $88 Million
Q4 2017 Feb 14, 2018	BUY	$307.64 - $344.58 $44 Million - $49.3 Million	142,949 Added 21.78%	799,372 $255 Million
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $185 Million - $216 Million	656,423	656,423 $206 Million

Others Institutions Holding BIIB

# of Institutions

1,050

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $28.7B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Putnam Investments LLC with notifications on news.

Account

Putnam Investments LLC Biogen Inc. Transaction History